Craft

Vergent Bioscience

Total Funding

$9.7 M

Vergent Bioscience Summary

Company Summary

Overview
Vergent Bioscience is a biotechnology company developing targeted molecular probes for cancer surgery. The probes are used to locate cancerous tissue with fluorescing dye to help surgeons locate and remove tumors during resection surgery. The solution can be used for cancers including lung, breast, ovarian, colorectal, and brain.
Type
Private
Status
Active
Founded
2016
HQ
Minneapolis, MN, US | view all locations
Website
https://www.vergentbio.com/
Cybersecurity rating
Sectors

Key People

  • John Santini

    John Santini, President & Chief Executive Officer

  • Eric Bensen

    Eric Bensen, Vice President, Research and Development

  • Curtis Scribner

    Curtis Scribner, Chief Medical Officer

    • Maggie Neptune

      Maggie Neptune, Vice President, Clinical Operations

    Operating MetricsView all

    Active Investors

    6

    May, 2023

    LocationsView all

    1 location detected

    • Minneapolis, MN HQ

      United States

      5810 W 78th St #222

    Footer menu